Note: Ingredients listed on restricted chemical lists
EC/CAS
50-00-0
Name of the chemical
Formaldehyde
Concentration
N/A
EC/CAS
67-56-1
Name of the chemical
Methanol
Concentration
N/A
EC/CAS
200-001-8
Name of the chemical
Formaldehyd (605/2014)
Concentration
N/A
EC/CAS
200-659-6
Name of the chemical
Methanol
Concentration
N/A
General Information
Revision date
2021-01-03
Product name
BiopSafe Formaldehyde solution 4%
1.2.1 Relevant identified uses
For laboratory research and analytical purposes. Restricted to professional users
Emergency telephone
NHS (England or Wales) Dial 111 or 0845 4647 NHS 24 (Scotland) Dial 111
Icons in SDS
Company Information
company name
Biopsafe ApS
e-mail address of the competent person responsible for the Safety Data Sheet
lone@biopsafe.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H332, H317, H341, H350
Hazard statements
Code
Statements
H302+H332
Harmful if swallowed or if inhaled
Section 2
2.1 Classification of the substance or mixture
Carcinogenic, sensitizing fluid with long-term effects. Suspected of causing genetic defects. CLP (1272/2008): Acute Tox. 4;H302+H332 Skin Sens. 1;H317 Muta. 2;H341 Carc. 1B;H350
2.2 Label elements
DANGER
Contains
Formaldehyde; methanol H302+H332: Harmful if swallowed or if inhaled. H317: May cause an allergic skin reaction. H341: Suspected of causing genetic defects. H350: May cause cancer. P201: Obtain special instructions before use. P280: Wear protective gloves/eye protection/face protection. P260: Do not mist/vapours. P333+P313: If skin irritation or rash occurs: Get medical advice/attention. P304+P340+P312 IF INHALED Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. P308+P313: IF exposed or concerned: Get medical advice/attention. Restricted to professional users.
2.3 Other hazards
PBT/vPvB: No ingredients are PBT/vPvB, according to the criteria in REACH Annex XIII. Endocrine disrupting properties: The substances are not identified as having endocrine disrupting properties in accordance with the criteria set out in Regulation 2017/2100 or Regulation 2018/605.
